CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt

Ahmed Shawky, Hussein Sabit, Mahmoud Nazih, Khalid Baraka, Mokhtar El-Zawahry

Open source

DOI
10.1007/s44197-023-00113-4
Published
2023-05-18
Container
Journal of Epidemiology and Global Health
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s44197-023-00113-4,
  title = {CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt},
  author = {Ahmed Shawky and Hussein Sabit and Mahmoud Nazih and Khalid Baraka and Mokhtar El-Zawahry},
  year = {2023},
  journal = {Journal of Epidemiology and Global Health},
  doi = {10.1007/s44197-023-00113-4},
  url = {https://doi.org/10.1007/s44197-023-00113-4}
}

RIS

TY  - JOUR
TI  - CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt
AU  - Ahmed Shawky
AU  - Hussein Sabit
AU  - Mahmoud Nazih
AU  - Khalid Baraka
AU  - Mokhtar El-Zawahry
PY  - 2023
JO  - Journal of Epidemiology and Global Health
DO  - 10.1007/s44197-023-00113-4
UR  - https://doi.org/10.1007/s44197-023-00113-4
ER  - 

APA

Shawky, A., Sabit, H., Nazih, M., Baraka, K., & El-Zawahry, M. (2023). CYP2C19 Polymorphism in Ischemic Heart Disease Patients Taking Clopidogrel After Percutaneous Coronary Intervention in Egypt. Journal of Epidemiology and Global Health. https://doi.org/10.1007/s44197-023-00113-4

Source records